One day earlier, at Michael's penthouse in BGC. He entered the Virtual World and there he found himself in a laboratory with white walls surrounding the room, dical technology lining up the walls, and a central holographic interface displaying various data points and schematics. He navigated through the lab, examining the high-tech equipnt that was present there.
He found out that the Virtual World changed according to the kind of blueprint he'd want to inspect. If it's sothing related to dicine, it will create a virtual world akin to a pharmaceutical laboratory, complete with simulation stations for drug testing and molecular analysis.
When his focus shifted to dical devices, the environnt transford into an engineering workshop, equipped with 3D modeling platforms and prototype testing equipnt.
Fascinated by the adaptability of the Virtual World, Michael decided to delve deeper into the Alzheir's pill project. He initiated a simulation that mimicked the human brain's environnt, allowing him to observe how the nanoparticles interacted with amyloid plaques at a microscopic level.
This imrsive experience gave him valuable insights into potential improvents in the pill's formulation to enhance its effectiveness.
By the way, he bought the pills for 3,000 System Points. It was quite cheap due to its nature being a pill.
After hours of ticulous work in the virtual lab, Michael transitioned to the cancer treatnt pod project. He explored various engineering and design modifications to optimize the pod's functionality. Through interactive simulations, he tested different configurations, analyzing their efficiency in targeting cancer cells while minimizing harm to healthy tissues.
Throughout this process, Michael was not alone. Virtual assistants, powered by advanced AI, provided him with real-ti data analysis, research summaries, and technical support.
He found out that the Alzheir's pill dicine was 99.99 percent effective in reducing amyloid plaques in the simulated brain environnt. This result was beyond his initial expectations and highlighted the potential of the pill to make a significant impact on Alzheir's treatnt.
As for the cancer pod, or what he called the dipod. If you have forgotten, a technology designed to cure all kinds of cancer, was also effective.
Now the problem is the mass production of these miracle drugs and the dipod. The blueprint is there, the schematics are there, and the manufacturing process is there, but the manufacturing process itself is hard to replicate in the real-world due to the complexity of the machines needed to manufacture these advanced treatnts.
The precision required in the fabrication of the nanoparticles for the Alzheir's pill and the intricate components of the dipod demanded state-of-the-art manufacturing facilities, which were not introduced yet in this decade.
Michael sighed.
"I have to think of a narrative again," Michael muttered to himself.
To introduce a futuristic technology to this current year, Michael had always been considering the reaction of the public and the specialists. Like for example, how co a chanical engineering student cos up with a miracle drug without a background in pharmacology or dical science? He knew that credibility would be as crucial as the product itself in the market's eyes.
His solar panel was already attracting unwanted attention, questioning the credibility despite the facts through demonstration and experintation. It will be the sa in this field.
But the presentation is already tomorrow, and he had to show the investors sothing about this new enterprise.
"Ahh…forget it! Let's just do what must be done and then deal with the reactions later," Michael resolved, shaking off his doubts.
***
On the current day.
"The dipod," he started, "is more than just a treatnt device. It represents a new era in cancer care, combining diagnostic precision with targeted therapy and regenerative dicine. Its core technology allows for real-ti, full-body scans using the most advanced imaging techniques available today."
He clicked the remote, and the presentation screen lit up with images of the dipod. . "Using MRI, CT scans, and advanced PET technologies, the dipod can detect and localize even the smallest cancerous cells. This precision ans we can identify tumors at an earlier stage than ever before, significantly improving treatnt outcos."
"But wait you say," Michael paused, sensing the curiosity and skepticism in the room, "what about advanced-stage cancer? Can the dipod treat stages 3 to 5 effectively?"
He let the question hang in the air for a mont before continuing confidently, "Yes, it can. The dipod is designed to be effective across all stages of cancer. Its technology is not just for early detection but also for advanced treatnt."
He proceeded to explain, "For more advanced stages of cancer, where tumors have grown larger and perhaps tastasized, the dipod's targeted chemotherapy delivery system cos into play. The nanobots can be programd to target multiple tumor sites simultaneously, delivering high concentrations of chemotherapy directly to the cancer cells, regardless of their location in the body."
Michael then elaborated on the regenerative aspect of the dipod's treatnt process. "After the targeted destruction of cancerous cells, the dipod uses regenerative dicine to repair the damage. This includes not only the tissue damaged by the tumors but also any areas affected by the treatnt itself. It's a comprehensive approach to cancer care that looks at the patient holistically…."
As he was reporting, Bridget yawned. "I don't need to hear all those dical jargon to be honest, it bores . I only care if what you claim is true, otherwise it's just a fantasy."
"You're right, Bridget. At the end of the day, what matters is the real-world application and the tangible results," Michael acknowledged. "But I already have the technology in my secret lab."
"How do you expect us to back you up for this?" Antoinette interjected. "If you can't show us the actual technology, let alone a real result, then there's no reason for us to invest. It's a massive risk."
Michael t Antoinette's gaze.
"I understand your concerns," he replied and continued. "But here's the deal. I am confident in the dipod's capabilities and the pill's potential."
He paused for effect, then continued, "So, here's the choice I'm giving you: either you trust in my track record and the innovations I've brought to market, and we move forward together, or I will proceed to establish this enterprise on my own. If I go alone, and these technologies succeed, then unfortunately, you won't benefit from the windfall."
He let his words sink in, giving the investors ti to ponder the gravity of the decision before them.
"I'm here to change the world," Michael concluded, "and I invite you to be part of this journey. Together, we can create a legacy that will outlive us, a legacy of saving lives and changing the course of dical history. Heck, you might even get yourself a plaque in the hall of fa of dicine," Michael added with a hint of humor to lighten the mood.
Antoinette and Bridget exchanged looks.
"Ms von Reimann? What do you think about another stunt of Mr. Reyes? Is it going to be the sa as his solar panel and the electric vehicle?"
"If you ask , Michael has a way of turning the impossible into reality," Bridget replied thoughtfully. "His track record with SolaraTech and the electric vehicle innovation speaks volus. It's risky, yes, but the potential payoff is enormous."
Antoinette nodded slowly, her business acun kicking in. "The dical sector needs revolutionizing. If Michael's dipod and miracle pill can deliver as promised, we're looking at a ga-changer."
Michael observed the shift in their deanor. "I'm not asking you to leap blindly," he reassured. "I'm offering you a chance to be at the forefront of dical innovation. Yes, it's a venture that carries risks, but also one that promises significant rewards."
"You make it sound like we're on the brink of a dical renaissance," Antoinette said, a slight smile appearing.
"How much do you need?"
"Investnt such as this would require massive capital. I don't think you two can cover it all on your own," Michael interjected, seeing their intrigued yet cautious expressions. "To properly develop, test, and mass-produce the dipod and the pill, we're looking at an investnt of around 20 billion dollars."
The room fell silent at the ntion of the amount.
Bridget's eyebrows raised, "Twenty billion? That's a hefty sum, even by our standards."
Michael nodded. "Yes, it is. Of course, you two will be a major shareholder, and then I will look for soone else, soone you can recomnd who has the vision and financial strength to participate in this groundbreaking venture. We need partners who are willing to invest in the future, partners who understand the long-term impact of what we are creating."
Antoinette considered Michael's words carefully. "You're talking about bringing in more investors to share the load. That makes sense, given the scale of what you're proposing."
Michael leaned forward, his eyes locking with theirs. "Not only that, I'm ready to invest a significant portion of my personal fortune into this. I believe in it that much. So, are you in, or are you out?"
Reviews
All reviews (0)